Follow

Elliptic Laboratories ASA

Elliptic Laboratories is a research spin-off from Norway's Oslo University and is now a global enterprise targeting the smartphone, laptop, IoT and automotive markets. The Company's patented AI software combines ultrasound and sensor-fusion algorithms to deliver intuitive 3D gesture and presence sensing experiences.

Sector:
TECHNOLOGY
>
Software
Software & Computer Services
Status
This company has moved to a main market, therfore we do not show updates relating to this company.
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
ELABS
NO0010722283
Details of share in Elliptic Laboratories ASA with ticker ELABS
Status
Active
Amount of instruments
103 140 070
Currency
NOK
Listing
Sign in to buy
Private placement
Sign in to buy
Market move
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
ELABS-ME
NO0010722283
Euronext Growth Oslo
Norway (NO)
Details of share in Elliptic Laboratories ASA with ticker ELABS-ME
Status
Archived
Amount of instruments
9 584 591
Currency
NOK
Listing
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
ELABS
NO0010722283
Details of share in Elliptic Laboratories ASA with ticker ELABS
Status
Active
Amount of instruments
103 140 070
Currency
NOK
Private placement
Sign in to buy
Market move
Sign in to buy
People
Laila Beate Danielsen
CEO
Tore Engebretsen
Chairman of the board
Einar Jørgen Greve
Board member
Edvin Austbø
Board member
Sven Tore Larsen
Board member
Berit Svendsen
Board member
Company Details
Sector
TECHNOLOGY

Address
Akersgata 32
Zip code
0180
City/district
Oslo
Country
Norway (NO)
Registration number
989 750 186
LEI code
21380012EQMN8XOXBQ51
First trade date
16 Oct 2020
Company former names
Elliptic Laboratories AS
19 Jan 2022
Registration date
08 May 2006
Short name
ELABS

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More